Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

QuantumScape: Q2 Earnings Insights

QuantumScape (NYSE:QS) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings QuantumScape missed estimated earnings by 22.22%, reporting an EPS of $-0.22 versus an estimate of $-0.18.
byBenzinga Insights
July 27, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

QuantumScape (NYSE:QS) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

QuantumScape missed estimated earnings by 22.22%, reporting an EPS of $-0.22 versus an estimate of $-0.18.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 2.85% increase in the share price the next day.

To track all earnings releases for QuantumScape visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Celularity Announces Net Sales And Total Revenue Expectations; Expects Net Sales Of Its Biomaterial Products And Biobanking Businesses To Be In The Range Of $11.4M-$12.1M For Q4 2023 And $22.06M-$22.76M For FY23

By Benzinga Newsdesk
January 3, 1:02 PM
Celularity expects net sales of its biomaterial products and biobanking businesses to be in the range of $11.4 million to $12.1 million for the fourth quarter 2023 and $22.06 million to $22.76 million for the full year

CELU